PBH
NYSEPrestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc. (PBH) is a Biotechnology: Pharmaceutical Preparations company listed on NYSE. In the last 30 days Quantisnow tracked 4 wire items for PBH, including 2 earnings updates and 2 SEC filings. The most recent was published Nov 5, 2026.
PBH rankings
Financial highlights
Full financials- Revenue, TTM
- $1.17B
- Revenue growth
- +5.1%
- Net income, TTM
- $155.10M
- Net margin
- 13.3%
- Free cash flow, TTM
- $214.22M
- Cash
- $46.52M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks26+50%
2026-05-172026-11-08
Mix690d
- Other2(33%)
- Earnings2(33%)
- SEC Filings2(33%)
Activity · 52 weeks6433 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news
Latest news
25 items- SECSEC Form 10-Q filed by Prestige Consumer Healthcare Inc.10-Q - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Reports Fiscal 2027 Second Quarter ResultsQ2 Revenue of $336.3 million, up 22.7% versus prior yearQ2 Diluted EPS of $0.53; Adjusted Diluted EPS of $1.13, compared to prior year Adjusted Diluted EPS of $1.07The Breathe Right® portfolio and LaCorium acquisitions performed as expected in first full quarter of ownershipAdjusting guidance outlook range to $1,280 to $1,290 million in revenue, $4.48 to $4.55 in Adjusted Diluted EPS TARRYTOWN, N.Y., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and first half fiscal 2027 ended September 30, 2026. "We were pleased with our second quarter and first half revenue and EPS performance, driven by c
- PRPrestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings ResultsTARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to joi
- PRMore Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey FindsWhile 63% say women are more comfortable discussing intimate wellness than five years ago, new research reveals a gap between cultural progress and personal comfortTARRYTOWN, N.Y., Sept. 30, 2026 /PRNewswire/ -- Women may be talking more openly about intimate health and wellness, but that does not necessarily mean the discomfort has disappeared. New research from Summer's Eve® finds that while nearly two-thirds of U.S. women (63%) believe women today are more comfortable openly discussing intimate health and wellness than they were five years ago, more than half (52%) have personally avoided talking to someone about an intimate health and wellness concern because they felt embarrassed or unc
- PRPrestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer ConferenceTARRYTOWN, N.Y., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Ron Lombardi, Chairman, President, & CEO and Christine Sacco, CFO and COO will participate in a fireside chat at the Barclays Global Consumer Conference on Thursday, September 10, 2026 at 12:45 p.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors" section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those unable to participate during the live webcast, a replay option will be available on the Company’s website following the
- PRPrestige Consumer Healthcare Inc. to Participate in Canaccord Genuity Annual Growth ConferenceTARRYTOWN, N.Y., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that Christine Sacco, CFO and COO, and Phil Terpolilli, VP, Investor Relations, Treasury, & Business Development will participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference on Wednesday August 12, 2026 at 10:00 a.m. ET. A live webcast of this event will be available at www.prestigeconsumerhealthcare.com under the "Investors" section and the "Events and Presentations" tab, or by using the following link: https://ir.prestigebrands.com/events-presentations/events For those unable to participate during the live webcast, a replay option will be availab
- SECSEC Form 10-Q filed by Prestige Consumer Healthcare Inc.10-Q - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter ResultsQ1 Revenue of $265.7 million up 6.5% versus prior yearQ1 Organic sales growth of 3.2%, exceeding expectationsQ1 Diluted EPS of $0.61; Adjusted Diluted EPS of $0.98, up versus prior year $0.95Q1 Cash from Operating Activities $70.8 million; Q1 Adjusted Non-GAAP Free Cash Flow of $83.7 millionClosed the Breathe Right® and LaCorium acquisitions in June and July, respectivelyRaising fiscal 2027 outlook to include acquisitions; anticipate revenue of $1,290 to $1,315 million and Adjusted Diluted EPS outlook to $4.55 to $4.65 TARRYTOWN, N.Y., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first quarter fiscal 2027 ended Jun
- INSIDERDirector Zier Dawn M. was granted 2,981 shares, increasing direct ownership by 18% to 19,514 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERDirector Kelly John F. was granted 2,981 shares, increasing direct ownership by 61% to 7,832 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERDirector Darecca James was granted 2,981 shares, increasing direct ownership by 45% to 9,572 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERDirector Byom John E was granted 2,981 shares, increasing direct ownership by 6% to 54,575 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- INSIDERDirector Clark Celeste A. was granted 2,981 shares, increasing direct ownership by 22% to 16,511 units (SEC Form 4)4 - Prestige Consumer Healthcare Inc. (0001295947) (Issuer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECAmendment: Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Prestige Consumer Healthcare Inc.SCHEDULE 13G/A - Prestige Consumer Healthcare Inc. (0001295947) (Subject)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results DateTARRYTOWN, N.Y., July 06, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of LaCorium Health ("LaCorium"), priced a private offering of $400 million in senior notes, and will report its first quarter fiscal 2027 results on August 6, 2026. Completion of LaCorium Health Acquisition The Company completed the acquisition on July 1, 2026. The closing was finalized pursuant to the terms of the definitive agreement announced on May 13, 2026, under which Prestige agreed to acquire LaCorium for approximately $150 million in cash. The Company financed the transaction with cash on hand and exi
- PRPrestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior NotesTARRYTOWN, N.Y., June 30, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) (the "Company") announced today that its wholly-owned subsidiary, Prestige Brands, Inc. ("Prestige Brands"), intends to offer, subject to market and other conditions, up to $400 million in aggregate principal amount of new senior notes due 2034 (the "notes") in a private offering. The notes will be senior unsecured obligations of Prestige Brands and will be guaranteed by the Company and certain of its domestic subsidiaries. The Company intends to use the net proceeds from the proposed offering, together with cash on hand, to redeem all $400 million of Prestige Brands’ outstanding 5.125% Senior
- SECAmendment: Prestige Consumer Healthcare Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECSEC Form DEF 14A filed by Prestige Consumer Healthcare Inc.DEF 14A - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- SECPrestige Consumer Healthcare Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Prestige Consumer Healthcare Inc. (0001295947) (Filer)
- PRPrestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®TARRYTOWN, N.Y., June 15, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of the Breathe Right® brand and certain other brands. The closing was finalized pursuant to the terms of the asset purchase agreement, announced on March 20, 2026, under which Prestige agreed to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million. Breathe Right®, created in the 1990s, is an iconic #1 brand synonymous with the nasal strip category. It will become the
PBH FAQ
11 questionsWhat does Prestige Consumer Healthcare Inc. do?
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief...What is the latest news on PBH?
In the last 30 days Quantisnow tracked 4 wire items for PBH: 2 earnings updates and 2 SEC filings. The most recent was published on November 5, 2026.What is PBH revenue?
Prestige Consumer Healthcare Inc. (PBH) reported $1.17B of revenue for the twelve months ended Sep 30, 2026. That is up 5.1% from the year before. Revenue for fiscal 2026 was $1.09B.Is PBH profitable?
Yes. Prestige Consumer Healthcare Inc. earned $155.10M in net income for the twelve months ended Sep 30, 2026, a net margin of 13.3%.How much cash and debt does PBH have?
Prestige Consumer Healthcare Inc. reported $46.52M in cash and cash equivalents and $2.08B of debt on its most recent balance sheet in SEC filings.Where does PBH stock trade?
Prestige Consumer Healthcare Inc. (PBH) is listed on NYSE.What sector and industry is PBH in?
Prestige Consumer Healthcare Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Prestige Consumer Healthcare Inc. go public?
Prestige Consumer Healthcare Inc. (PBH) completed its IPO in 2005.What are analysts saying about PBH?
Across the last 8 analyst actions on Prestige Consumer Healthcare Inc., there were 4 upgrades and 2 downgrades. The most recent action was from Oppenheimer: Perform on 2026-05-14. Recent price targets range from $63.00 to $142.00.What companies are similar to PBH?
Notable peers in the same industry include AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABT (Abbott Laboratories), MRK (Merck & Company Inc.), ABBV (AbbVie Inc.). Compare PBH side-by-side with any of them on Quantisnow.How can I track PBH on Quantisnow?
Quantisnow aggregates Prestige Consumer Healthcare Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow PBH to receive live email and push alerts on every new disclosure.